Two-dimension tailor-made eradication therapy as the third-line therapy for Helicobacter pylori infection.
Not Applicable
- Conditions
- Helicobacter pylori infection
- Registration Number
- JPRN-UMIN000022154
- Lead Sponsor
- Department of General Medicine, JCHO Shiga Hospital
- Brief Summary
Eradication rate of 2-dimension tailor-made therapy (2dTMT) was 86.4% (95%CI: 65.1-98.8%) in ITT and 90.5% (95%CI: 69.6-98.8%) in PP analyses. Eradication rate of 1-dimension tailor-made therapy (1dTMT) was 75.0% (95%CI: 42.8-94.5%) in ITT and 90.0% (95%CI: 55.5-99.7%)in PP analyses.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 51
Inclusion Criteria
Not provided
Exclusion Criteria
Those who do not want to undergo eradication therapy anymore. Those who discontinued previous eradication therapies because of adverse events. Those who have severe liver or renal diseases or other conditions which are not adequate to enter the study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Eradication success is evaluated 2 months or later after eradication therapy.
- Secondary Outcome Measures
Name Time Method Safety is evaluated with adverse events during the therapy.